| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | microtubule minus-end binding | 3.62e-05 | 15 | 88 | 3 | GO:0051011 | |
| GeneOntologyMolecularFunction | actin binding | 2.60e-04 | 479 | 88 | 9 | GO:0003779 | |
| GeneOntologyCellularComponent | cell projection membrane | 8.39e-05 | 431 | 88 | 9 | GO:0031253 | |
| GeneOntologyCellularComponent | filopodium membrane | 9.08e-05 | 21 | 88 | 3 | GO:0031527 | |
| GeneOntologyCellularComponent | costamere | 1.05e-04 | 22 | 88 | 3 | GO:0043034 | |
| GeneOntologyCellularComponent | actin-based cell projection | 1.73e-04 | 278 | 88 | 7 | GO:0098858 | |
| GeneOntologyCellularComponent | spectrin | 6.19e-04 | 9 | 88 | 2 | GO:0008091 | |
| GeneOntologyCellularComponent | actin cytoskeleton | 7.11e-04 | 576 | 88 | 9 | GO:0015629 | |
| GeneOntologyCellularComponent | paraspeckles | 7.71e-04 | 10 | 88 | 2 | GO:0042382 | |
| GeneOntologyCellularComponent | cell-cell junction | 8.53e-04 | 591 | 88 | 9 | GO:0005911 | |
| GeneOntologyCellularComponent | unconventional myosin complex | 9.40e-04 | 11 | 88 | 2 | GO:0016461 | |
| GeneOntologyCellularComponent | supramolecular fiber | JPH1 NES MYO1C MYO9A AHNAK TRIM55 FMN2 MACF1 NCKAP5 DMD CAMSAP1 TUBGCP5 VCL | 1.27e-03 | 1179 | 88 | 13 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | JPH1 NES MYO1C MYO9A AHNAK TRIM55 FMN2 MACF1 NCKAP5 DMD CAMSAP1 TUBGCP5 VCL | 1.35e-03 | 1187 | 88 | 13 | GO:0099081 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | NES MYO1C MYO9A TRIM55 FMN2 MACF1 NCKAP5 DMD CAMSAP1 TUBGCP5 VCL | 1.36e-03 | 899 | 88 | 11 | GO:0099513 |
| GeneOntologyCellularComponent | microvillus | 1.82e-03 | 123 | 88 | 4 | GO:0005902 | |
| HumanPheno | Gastroparesis | 2.61e-05 | 34 | 27 | 4 | HP:0002578 | |
| Domain | GAGE | 1.02e-04 | 19 | 91 | 3 | IPR031320 | |
| Domain | GAGE | 1.02e-04 | 19 | 91 | 3 | SM01379 | |
| Domain | GAGE | 2.10e-04 | 24 | 91 | 3 | PF05831 | |
| Domain | GAGE_fam | 2.38e-04 | 25 | 91 | 3 | IPR008625 | |
| Pathway | WP_PRION_DISEASE_PATHWAY | 1.11e-05 | 32 | 62 | 4 | M39636 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | SYNRG FAM193B DSC1 PRPF3 RBBP6 AHNAK MACF1 TACC2 CAMSAP1 DHX29 NKRF AFF4 EPB41L2 VCL RAD21 | 3.15e-08 | 934 | 94 | 15 | 33916271 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DDX19B NES SYNRG MDN1 MYO9A AHNAK RAB3GAP2 FMN2 MAGI3 MACF1 CAMSAP1 EPB41L2 MADD C6orf132 | 8.15e-08 | 861 | 94 | 14 | 36931259 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NES DDX19A DNAJB11 MDN1 DSC1 MYO1C MYO9A PRPF3 AHNAK MACF1 CHD2 YBX3 ALDH1B1 DHX29 NKRF EPB41L2 VCL | 1.20e-07 | 1353 | 94 | 17 | 29467282 |
| Pubmed | JPH1 DNAJB11 TAF3 MYO1C PRPF3 RBBP6 FAT3 ASH1L FMN2 MACF1 BCL11A TUBGCP5 NKRF AFF4 | 1.81e-06 | 1116 | 94 | 14 | 31753913 | |
| Pubmed | 2.61e-06 | 430 | 94 | 9 | 32581705 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 3.26e-06 | 231 | 94 | 7 | 16452087 | |
| Pubmed | 3.55e-06 | 234 | 94 | 7 | 36243803 | ||
| Pubmed | DNAJB11 PPP2R3A MTMR11 MYO1C SLC4A1AP PRPF3 AHNAK SCYL3 PLCL2 FMN2 XRCC1 DMD MADD | 5.00e-06 | 1049 | 94 | 13 | 27880917 | |
| Pubmed | FIP200 is required for maintenance and differentiation of postnatal neural stem cells. | 6.81e-06 | 14 | 94 | 3 | 23542691 | |
| Pubmed | A Surveillance Mechanism Ensures Repair of DNA Lesions during Zygotic Reprogramming. | 7.23e-06 | 2 | 94 | 2 | 27916276 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 16704730 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 20557674 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 7919966 | ||
| Pubmed | Talin, vinculin and nestin expression in orofacial muscles of dystrophin deficient mdx mice. | 7.23e-06 | 2 | 94 | 2 | 22307364 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 30699353 | ||
| Pubmed | 9.68e-06 | 506 | 94 | 9 | 30890647 | ||
| Pubmed | 1.12e-05 | 653 | 94 | 10 | 22586326 | ||
| Pubmed | SYNRG DNAJB11 RAB3GAP2 PRKCB MACF1 NCAM1 TACC2 ALDH1B1 CAMSAP1 DHX29 ELFN2 EPB41L2 MADD | 1.20e-05 | 1139 | 94 | 13 | 36417873 | |
| Pubmed | 1.52e-05 | 407 | 94 | 8 | 12693553 | ||
| Pubmed | Ca2+-dependent proteolysis of junctophilin-1 and junctophilin-2 in skeletal and cardiac muscle. | 2.16e-05 | 3 | 94 | 2 | 23148318 | |
| Pubmed | FXYD6 is a novel regulator of Na,K-ATPase expressed in the inner ear. | 2.16e-05 | 3 | 94 | 2 | 17209044 | |
| Pubmed | [Functional Hypermethylation of ALDH1L1, PLCL2, and PPP2R3A in Colon Cancer]. | 2.16e-05 | 3 | 94 | 2 | 32392189 | |
| Pubmed | Fxr1 knockout mice show a striated muscle phenotype: implications for Fxr1p function in vivo. | 2.16e-05 | 3 | 94 | 2 | 15128702 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 36238292 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 8040390 | ||
| Pubmed | Molecular cloning and characterization of a novel phospholemman-like protein from rat hippocampus. | 2.16e-05 | 3 | 94 | 2 | 11165386 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 24068741 | ||
| Pubmed | RNA export factor Ddx19 is required for nuclear import of the SRF coactivator MKL1. | 2.16e-05 | 3 | 94 | 2 | 25585691 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 12743109 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 12711699 | ||
| Pubmed | Non-EST based prediction of exon skipping and intron retention events using Pfam information. | 2.16e-05 | 3 | 94 | 2 | 16204458 | |
| Pubmed | JPH1 MYO9A AHNAK RAB3GAP2 MAGI3 MACF1 CAMSAP1 DHX29 EPB41L2 VCL | 2.23e-05 | 708 | 94 | 10 | 39231216 | |
| Pubmed | 2.30e-05 | 209 | 94 | 6 | 36779422 | ||
| Pubmed | Analysis of BCL6-interacting proteins by tandem mass spectrometry. | 2.48e-05 | 62 | 94 | 4 | 16147992 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 2.83e-05 | 444 | 94 | 8 | 34795231 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 2.91e-05 | 582 | 94 | 9 | 20467437 | |
| Pubmed | NES MYO1C MYO9A PRKCB MACF1 NCAM1 BCL11A ALDH1B1 DMD DHX29 ELFN2 EPB41L2 VCL MADD | 3.00e-05 | 1431 | 94 | 14 | 37142655 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 4.01e-05 | 759 | 94 | 10 | 35915203 | |
| Pubmed | JPH1 TTYH1 SGSM2 ASH1L CCDC15 FMN2 MAGI3 MACF1 NCKAP5 KDM4A TUBGCP5 AFF4 MADD | 4.22e-05 | 1285 | 94 | 13 | 35914814 | |
| Pubmed | FXYD6, a Na,K-ATPase regulator, is expressed in type II taste cells. | 4.32e-05 | 4 | 94 | 2 | 21670532 | |
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 9724777 | ||
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 35766181 | ||
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 8954775 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SYNRG FAM193B TLK1 MDN1 SGSM2 AHNAK NLRC5 SFI1 TNRC6C CAMSAP1 MADD C6orf132 | 4.33e-05 | 1105 | 94 | 12 | 35748872 |
| Pubmed | 4.51e-05 | 347 | 94 | 7 | 17114649 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TLK1 PPP2R3A MYO9A PRPF3 SIGIRR SGSM2 ASH1L NLRC5 MAGI3 MACF1 CHD2 TNRC6C ADCY3 AFF4 | 4.62e-05 | 1489 | 94 | 14 | 28611215 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SYNRG TLK1 TAF3 MDN1 MYO1C SLC4A1AP RBBP6 YBX3 DHX29 EPB41L2 | 4.73e-05 | 774 | 94 | 10 | 15302935 |
| Pubmed | Transcriptional profiling of sequentially generated septal neuron fates. | 4.75e-05 | 26 | 94 | 3 | 34851821 | |
| Pubmed | PPP2R3A MYO1C AHNAK SCYL3 LRRK2 NCAM1 PODXL2 CAMSAP1 PCDH9 EPB41L2 | 4.88e-05 | 777 | 94 | 10 | 35844135 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | JPH1 DNAJB11 DSC1 MYO1C PRPF3 RBBP6 AHNAK YBX3 XRCC1 CPS1 NKRF | 5.17e-05 | 949 | 94 | 11 | 36574265 |
| Pubmed | 5.34e-05 | 486 | 94 | 8 | 20936779 | ||
| Pubmed | Synemin acts as a regulator of signalling molecules during skeletal muscle hypertrophy. | 5.96e-05 | 28 | 94 | 3 | 25179606 | |
| Pubmed | 5.99e-05 | 152 | 94 | 5 | 34299191 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | JPH1 PAGE1 TLK1 PRPF3 CNOT10 AHNAK CCDC15 TACC2 CPS1 TUBGCP5 VCL RAD21 | 6.62e-05 | 1155 | 94 | 12 | 20360068 |
| Pubmed | 7.19e-05 | 5 | 94 | 2 | 18849981 | ||
| Pubmed | 7.19e-05 | 5 | 94 | 2 | 21451103 | ||
| Pubmed | Role of dystrophins and utrophins in platelet adhesion process. | 7.19e-05 | 5 | 94 | 2 | 16803572 | |
| Pubmed | 7.19e-05 | 5 | 94 | 2 | 28300292 | ||
| Pubmed | Predominant expression of Brn-2 in the postmitotic neurons of the developing mouse neocortex. | 7.19e-05 | 5 | 94 | 2 | 9106466 | |
| Pubmed | Localization of the membrane-anchored MMP-regulator RECK at the neuromuscular junctions. | 7.19e-05 | 5 | 94 | 2 | 17953659 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | NES MDN1 DSC1 MYO1C SLC4A1AP AHNAK ALDH1B1 NKRF AFF4 VCL RAD21 | 7.47e-05 | 989 | 94 | 11 | 36424410 |
| Pubmed | 7.66e-05 | 660 | 94 | 9 | 32780723 | ||
| Pubmed | Interactome analysis reveals that lncRNA HULC promotes aerobic glycolysis through LDHA and PKM2. | 7.87e-05 | 161 | 94 | 5 | 32572027 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 9.97e-05 | 394 | 94 | 7 | 27248496 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 1.01e-04 | 533 | 94 | 8 | 30554943 | |
| Pubmed | 1.08e-04 | 6 | 94 | 2 | 12149647 | ||
| Pubmed | 1.08e-04 | 6 | 94 | 2 | 19778507 | ||
| Pubmed | CHD2 is Required for Embryonic Neurogenesis in the Developing Cerebral Cortex. | 1.08e-04 | 6 | 94 | 2 | 25786798 | |
| Pubmed | 1.08e-04 | 6 | 94 | 2 | 26712358 | ||
| Pubmed | Histone deacetylase SIRT1 modulates neuronal differentiation by its nuclear translocation. | 1.08e-04 | 6 | 94 | 2 | 18829436 | |
| Pubmed | Impaired generation of mature neurons by neural stem cells from hypomorphic Sox2 mutants. | 1.08e-04 | 6 | 94 | 2 | 18171687 | |
| Pubmed | 1.08e-04 | 6 | 94 | 2 | 18829510 | ||
| Pubmed | Phosphorylation of the vasodilator-stimulated phosphoprotein regulates its interaction with actin. | 1.08e-04 | 6 | 94 | 2 | 10882740 | |
| Pubmed | 1.08e-04 | 6 | 94 | 2 | 17171436 | ||
| Pubmed | 1.08e-04 | 6 | 94 | 2 | 29772070 | ||
| Pubmed | Developmental diversification of cortical inhibitory interneurons. | 1.12e-04 | 91 | 94 | 4 | 29513653 | |
| Pubmed | 1.18e-04 | 281 | 94 | 6 | 24163370 | ||
| Pubmed | TLK1 MDN1 MYO1C TCHHL1 AHNAK ASH1L MAGI3 MACF1 CHD2 YBX3 ALDH1B1 STOX1 DMD | 1.34e-04 | 1442 | 94 | 13 | 35575683 | |
| Pubmed | 1.50e-04 | 7 | 94 | 2 | 23266827 | ||
| Pubmed | 1.50e-04 | 7 | 94 | 2 | 14499644 | ||
| Pubmed | Genome-wide association study of HLA-DQB1*06:02 negative essential hypersomnia. | 1.50e-04 | 7 | 94 | 2 | 23646285 | |
| Pubmed | 1.50e-04 | 7 | 94 | 2 | 22956851 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 1.51e-04 | 565 | 94 | 8 | 25468996 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | NES DNAJB11 TAF3 PRPF3 RBBP6 MACF1 PODXL2 CHD2 TNXB NKRF AFF4 | 1.64e-04 | 1082 | 94 | 11 | 38697112 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 1.74e-04 | 736 | 94 | 9 | 29676528 | |
| Pubmed | 1.88e-04 | 916 | 94 | 10 | 32203420 | ||
| Pubmed | MDN1 SLC4A1AP RBBP6 CNOT10 MACF1 CHD2 XRCC1 DHX29 NKRF AFF4 EPB41L2 C6orf132 RAD21 | 1.94e-04 | 1497 | 94 | 13 | 31527615 | |
| Pubmed | Novel obscurins mediate cardiomyocyte adhesion and size via the PI3K/AKT/mTOR signaling pathway. | 2.00e-04 | 8 | 94 | 2 | 28826662 | |
| Pubmed | 2.00e-04 | 8 | 94 | 2 | 19619134 | ||
| Pubmed | 2.00e-04 | 8 | 94 | 2 | 12475935 | ||
| Pubmed | BASP1 labels neural stem cells in the neurogenic niches of mammalian brain. | 2.00e-04 | 8 | 94 | 2 | 33692421 | |
| Pubmed | 2.00e-04 | 8 | 94 | 2 | 18586242 | ||
| Pubmed | 2.00e-04 | 8 | 94 | 2 | 27280679 | ||
| Pubmed | 2.00e-04 | 8 | 94 | 2 | 27166167 | ||
| Pubmed | Ena/VASP Is Required for neuritogenesis in the developing cortex. | 2.00e-04 | 8 | 94 | 2 | 17988629 | |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | MYO1C MYO9A AHNAK XRCC1 BCL6 SPOCD1 DHX29 ADCY3 EPB41L2 MADD | 2.03e-04 | 925 | 94 | 10 | 28986522 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | TLK1 PRPF3 NEK5 CNOT10 GDAP2 AHNAK CCDC154 PLCL2 PCDH9 VASP NKRF VCL | 2.32e-04 | 1321 | 94 | 12 | 27173435 |
| Pubmed | 2.32e-04 | 203 | 94 | 5 | 35012549 | ||
| Pubmed | 2.47e-04 | 322 | 94 | 6 | 26514267 | ||
| Pubmed | 2.57e-04 | 9 | 94 | 2 | 12798291 | ||
| Coexpression | GSE40274_CTRL_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 5.88e-07 | 198 | 94 | 8 | M9119 | |
| Coexpression | GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN | 7.66e-06 | 199 | 94 | 7 | M5799 | |
| Coexpression | GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_WT_LIVER_DN | 7.92e-06 | 200 | 94 | 7 | M5980 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | JPH1 DDX19A SLC4A1AP MYO9A RBBP6 FAT3 SCYL3 ASH1L CCDC15 FMN2 NCKAP5 CHD2 BCL11A DMD CAMSAP1 NKRF AFF4 | 6.44e-08 | 831 | 90 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | JPH1 DDX19B SYNRG SLC4A1AP RBBP6 FAT3 FMN2 NCAM1 NCKAP5 CHD2 DMD PCDH9 NKRF MADD | 6.28e-07 | 654 | 90 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.29e-06 | 328 | 90 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | JPH1 TTYH1 DDX19B NES MDN1 SLC4A1AP RBBP6 FAT3 FMN2 CHD2 BCL11A DMD PCDH9 NKRF MADD | 1.53e-05 | 983 | 90 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | B cells, B.Fo.PC, IgD+ IgM+ CD19+ CD43- CD5- CD23+, Peritoneal Cavity, avg-3 | 1.85e-05 | 352 | 90 | 9 | GSM538198_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.99e-05 | 271 | 90 | 8 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | TTYH1 SYNRG FAT3 FMN2 NCAM1 PODXL2 NCKAP5 CHD2 DMD PCDH9 MADD RAD21 | 3.30e-05 | 688 | 90 | 12 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | TTYH1 NES SYNRG FAT3 FMN2 NCAM1 PODXL2 NCKAP5 DMD PCDH9 MADD | 5.68e-05 | 614 | 90 | 11 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#1 | 6.04e-05 | 233 | 90 | 7 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000_k-means-cluster#4 | 8.70e-05 | 247 | 90 | 7 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#2 | 9.15e-05 | 249 | 90 | 7 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | JPH1 TTYH1 DDX19B NES SYNRG FAT3 FMN2 NCAM1 PODXL2 NCKAP5 DMD PCDH9 MADD | 9.67e-05 | 893 | 90 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#2 | TTYH1 SYNRG FAT3 FMN2 MACF1 NCAM1 PODXL2 NCKAP5 DMD PCDH9 MADD | 1.06e-04 | 659 | 90 | 11 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | DDX19A SLC4A1AP MYO9A RBBP6 SCYL3 ASH1L MACF1 CHD2 KDM4A BCL11A CAMSAP1 AFF4 | 1.10e-04 | 780 | 90 | 12 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | B cells, B.T2.Sp, IgD+ IgM+ CD45R+ CD24+ CD19+ AA4.1+ CD23+, Spleen, avg-3 | 1.16e-04 | 348 | 90 | 8 | GSM538216_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#4 | JPH1 TTYH1 SYNRG FAT3 FMN2 NCAM1 PODXL2 NCKAP5 DMD PCDH9 MADD | 1.46e-04 | 683 | 90 | 11 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K4 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_200 | 1.58e-04 | 64 | 90 | 4 | gudmap_developingGonad_e18.5_epididymis_200_k5 | |
| CoexpressionAtlas | B cells, B.FrF.BM, CD19+ IgM+ AA4.1- HSA+, Bone marrow, avg-3 | 1.67e-04 | 367 | 90 | 8 | GSM399440_500 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4 | TTYH1 SYNRG FAT3 FMN2 NCAM1 PODXL2 NCKAP5 TNRC6C DMD PCDH9 MADD | 2.33e-04 | 721 | 90 | 11 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 2.39e-04 | 291 | 90 | 7 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | 2.43e-04 | 493 | 90 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#3 | TTYH1 SYNRG FAT3 FMN2 NCAM1 PODXL2 NCKAP5 TNRC6C DMD PCDH9 MADD | 2.59e-04 | 730 | 90 | 11 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | TTYH1 DDX19B NES RBBP6 FAT3 CCDC15 FMN2 NCKAP5 CHD2 YBX3 BCL11A DMD NKRF | 2.64e-04 | 989 | 90 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.72e-04 | 210 | 90 | 6 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K2 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#2_top-relative-expression-ranked_500 | 2.84e-04 | 136 | 90 | 5 | gudmap_developingGonad_P2_epididymis_500_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5 | JPH1 TTYH1 SYNRG FAT3 FMN2 NCAM1 PODXL2 NCKAP5 DMD PCDH9 MADD | 3.01e-04 | 743 | 90 | 11 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#2 | TTYH1 SYNRG FAT3 FMN2 NCAM1 PODXL2 NCKAP5 TNRC6C DMD PCDH9 MADD | 3.15e-04 | 747 | 90 | 11 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000_k-means-cluster#4 | 3.75e-04 | 223 | 90 | 6 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 4.62e-04 | 232 | 90 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5 | 4.69e-04 | 658 | 90 | 10 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K5 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_500 | 4.74e-04 | 152 | 90 | 5 | gudmap_developingGonad_e18.5_epididymis_500_k4 | |
| CoexpressionAtlas | B cells, B1b.PC, IgD+ IgM+ CD19+ CD43+ CD5- CD45R+, Peritoneal Cavity, avg-2 | 5.77e-04 | 337 | 90 | 7 | GSM538228_500 | |
| CoexpressionAtlas | CD positive, CD19 Control, 19+ 4- 8-, Spleen, avg-6 | 5.97e-04 | 339 | 90 | 7 | GSM403988_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#5_top-relative-expression-ranked_200 | 6.09e-04 | 91 | 90 | 4 | gudmap_developingGonad_e14.5_ epididymis_200_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_500_k-means-cluster#4 | 6.34e-04 | 92 | 90 | 4 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_500_K4 | |
| CoexpressionAtlas | B cells, B.Fo.Sp, IgD+ IgM+ CD45R+ CD24+ CD19+ AA4.1- CD23+, Spleen, avg-3 | 6.62e-04 | 345 | 90 | 7 | GSM538201_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.70e-04 | 164 | 90 | 5 | gudmap_developingGonad_e11.5_testes and mesonephros_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_200 | 7.07e-04 | 166 | 90 | 5 | gudmap_developingGonad_e18.5_epididymis_200 | |
| CoexpressionAtlas | B cells, B.T3.Sp, IgD+ IgM+ CD45R+ CD24+ CD19+ AA4.1+ CD23+, Spleen, avg-3 | 8.64e-04 | 361 | 90 | 7 | GSM538219_500 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 5.08e-09 | 182 | 94 | 8 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-8|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.16e-07 | 181 | 94 | 7 | ca34d83daca10c5fa52ecdf4eba7d31b4e7e056e | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.79e-07 | 193 | 94 | 7 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_A2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-06 | 161 | 94 | 6 | 8ec923c230a7a3cce5edf2a736b3a00d607c698a | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-06 | 163 | 94 | 6 | 132aece9c79499b4bb3c2bde68d3d7202e1d8772 | |
| ToppCell | Control-Lymphoid-pDC|Control / Condition, Lineage and Cell class | 2.01e-06 | 176 | 94 | 6 | 5de16ff65476bde8b23322a44e11412e14f1bafe | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_A2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.01e-06 | 176 | 94 | 6 | 052b54c4337ca728974a106b6dbd3b72dd28eb23 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.08e-06 | 177 | 94 | 6 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | droplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-06 | 180 | 94 | 6 | dd1b10c7f5a0fbc63163844ca1882884a24a84d3 | |
| ToppCell | droplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-06 | 180 | 94 | 6 | 423454e3390080ae03bb3cbb267255ebfe4df080 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-06 | 183 | 94 | 6 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-06 | 183 | 94 | 6 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | 5'-Adult-LargeIntestine-Neuronal-Glial_mature|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.69e-06 | 185 | 94 | 6 | f607b6ee579562e2f92103fa5c7053df0170a229 | |
| ToppCell | 5'-Adult-LargeIntestine-Neuronal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.69e-06 | 185 | 94 | 6 | 317f2c854f00aa5957319b818c85eeed7d72ec7f | |
| ToppCell | 5'-Adult-LargeIntestine-Neuronal-Glial_mature-Adult_Glia|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.69e-06 | 185 | 94 | 6 | 7bb8fdfe04f85d25056380ec58222366de323a21 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l30|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.86e-06 | 187 | 94 | 6 | 6f7f293c9cf35261e0e3614e46ec1fb00a701b63 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 2.86e-06 | 187 | 94 | 6 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 3.04e-06 | 189 | 94 | 6 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 3.04e-06 | 189 | 94 | 6 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 3.13e-06 | 190 | 94 | 6 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | Fetal_29-31_weeks-Immune-B_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.23e-06 | 191 | 94 | 6 | 84452125d1b5b76974e3f9126f611eff16d45c25 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 3.23e-06 | 191 | 94 | 6 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-8|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.53e-06 | 194 | 94 | 6 | e9c907b8ec4329946338cca5ce8e954fa2cec37b | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 3.53e-06 | 194 | 94 | 6 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 3.53e-06 | 194 | 94 | 6 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-06 | 195 | 94 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.86e-06 | 197 | 94 | 6 | b2f4d7c301c0b24003374923b31d6d058e40b213 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.97e-06 | 198 | 94 | 6 | 5e70246a9ce199cb2fb5379912b8ab59456219e4 | |
| ToppCell | healthy_donor-Lymphocytic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 4.09e-06 | 199 | 94 | 6 | 2841e16d54acd344ba454f024e285c28abc37319 | |
| ToppCell | Transverse-B_cell-B_cell_cycling|B_cell / Region, Cell class and subclass | 4.09e-06 | 199 | 94 | 6 | 170ae68963d31f3b821b6f0e8f0c039bea0bc981 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_only / Treatment groups by lineage, cell group, cell type | 4.21e-06 | 200 | 94 | 6 | 7c62678cf408aaaf98d6df0fb27814d2007c4521 | |
| ToppCell | Severe-B_naive-8|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.41e-05 | 145 | 94 | 5 | a24cad86509208bc7267b02ef1d1b0a25a2a7043 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-05 | 147 | 94 | 5 | 9d7e965fe61bd7b31e09c4b2129a5a98c36f4811 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-05 | 147 | 94 | 5 | 38552953ff65a0fc20bee6ef57dc5885306ad18b | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.01e-05 | 156 | 94 | 5 | 841d653d74c4de41d2f9a114f6ccb92d6a1ebc24 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.01e-05 | 156 | 94 | 5 | a917b3e799a7b2a3c7f36af61f2b69292c0fb5c0 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Fibroblasts|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.07e-05 | 157 | 94 | 5 | f086753b51860e23f1275bd75e8802d2a7d7b70a | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122|Adult / Lineage, Cell type, age group and donor | 2.07e-05 | 157 | 94 | 5 | 31d1bd9138c60e8485664ec4144f987226e3eef9 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-11|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.27e-05 | 160 | 94 | 5 | 8396afbc7d919ba190863d50aa0ef8b9942a9866 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.34e-05 | 161 | 94 | 5 | 347edb0de10850b7d16c40945751033289289c9b | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-13|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.41e-05 | 162 | 94 | 5 | 28b3a6ae5519a267eefb70436d3190a387d027b9 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.48e-05 | 163 | 94 | 5 | 6bed27d2f67a430a847da5eb47878d14b4949c45 | |
| ToppCell | LA-16._Neuronal|World / Chamber and Cluster_Paper | 2.87e-05 | 168 | 94 | 5 | 2fd1fd2a16ac1c5eb028f93cc3a2477c7747693e | |
| ToppCell | Mild/Remission-B_naive-4|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.95e-05 | 169 | 94 | 5 | c3a6179a64589a370108fea809b157839347759c | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-05 | 169 | 94 | 5 | 8f397cf4f9fd7c6fa88d01a95289ce2a6bc6938d | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.21e-05 | 172 | 94 | 5 | 62ed3b70fa1f6c84ea80ff00f60d2562be292e9d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.30e-05 | 173 | 94 | 5 | d56e337eae727a29cd53cfd628e1b3c0a98e1f51 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.39e-05 | 174 | 94 | 5 | 165e14cad57e90aa247dcecfaa3c2e8ff2a470ad | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.39e-05 | 174 | 94 | 5 | 4289dfc7613db4bb3d706b9b65d06e84c0c53558 | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.58e-05 | 176 | 94 | 5 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr-Excitatory_Neuron.Slc17a7.Nptxr-Drd1_(Deep_layer_pyramidal_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.58e-05 | 176 | 94 | 5 | 3c76a5c4ca2b378667cb155fbb9675519572b35d | |
| ToppCell | Control-Lymphoid-ILC_B|World / Disease state, Lineage and Cell class | 3.58e-05 | 176 | 94 | 5 | 57ad9c9f5fda6bc24695587ed14190514fd8d96a | |
| ToppCell | Control-Lymphoid-ILC_B|Control / Disease state, Lineage and Cell class | 3.68e-05 | 177 | 94 | 5 | 3d0f4b4054185ba77071efbe53df34fee84b9b24 | |
| ToppCell | B_cells-Naive_B_cells_|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 3.78e-05 | 178 | 94 | 5 | 71ac2eca5cf13a91f86b80690748b0788392dcfc | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.89e-05 | 179 | 94 | 5 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | 5'-Adult-SmallIntestine-Neuronal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.99e-05 | 180 | 94 | 5 | 5e6e38ee0758ef2342a6a821c78ed24b57bb7b11 | |
| ToppCell | 5'-Adult-SmallIntestine-Neuronal-Glial_mature-Adult_Glia|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.99e-05 | 180 | 94 | 5 | b88cd7ae922782176c057342d1b9eb9b8e5e7204 | |
| ToppCell | 5'-Adult-SmallIntestine-Neuronal-Glial_mature|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.99e-05 | 180 | 94 | 5 | ebd6e719a03f25155fa8181be19469d04d6d10a6 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 4.10e-05 | 181 | 94 | 5 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | Influenza_Severe-B_naive|World / Disease group and Cell class | 4.20e-05 | 182 | 94 | 5 | e4885a5e6065c9c403cb2d305228691d6ae4ecb6 | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-05 | 182 | 94 | 5 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | remission-B_naive|World / disease stage, cell group and cell class | 4.20e-05 | 182 | 94 | 5 | cc1dfd2de35aee1a26f7efd78e108b60a3556ec5 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC1|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.20e-05 | 182 | 94 | 5 | 6f5228ac47f9ab46d165740cf2655b5ba217acbe | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Early_airway_SMC_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.32e-05 | 183 | 94 | 5 | a1d4f25e13f5b9e92a9ca0a804a7bed5df8fb2fe | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 4.32e-05 | 183 | 94 | 5 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 4.32e-05 | 183 | 94 | 5 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 4.43e-05 | 184 | 94 | 5 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | wk_20-22-Epithelial-PNS-intermediate_Schwann|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.43e-05 | 184 | 94 | 5 | 4e3ba64692868563a579902aa9c6f88cab5bce26 | |
| ToppCell | cellseq-Epithelial-Epithelial_Neuro-Secretory-Tuft-Tuft|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.54e-05 | 185 | 94 | 5 | 1fbdc96da0623c3935ae9d29dcb4ba9c474e5c21 | |
| ToppCell | cellseq-Epithelial-Epithelial_Neuro-Secretory-Tuft|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.54e-05 | 185 | 94 | 5 | b45487daac116e3d3d65ac2b0f81d1bf7d1a1914 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 4.54e-05 | 185 | 94 | 5 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.78e-05 | 187 | 94 | 5 | 3748203b62abf51b74dfcfc4f18b3ba831b63a96 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-23|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.78e-05 | 187 | 94 | 5 | 69b47f00598d647e2a99427ebddf42c339428e47 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-CD79a_B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.78e-05 | 187 | 94 | 5 | b51af2824e65734f333b1325117f4a2e88b17c23 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-8|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.78e-05 | 187 | 94 | 5 | c10d6a774b3e83f64e47b9ad08f5d6b0dc60d163 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.78e-05 | 187 | 94 | 5 | 3ca3954f45f167e98a230f2847f0582d74fcd32e | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.91e-05 | 188 | 94 | 5 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | IPF-Myeloid-cDC1|IPF / Disease state, Lineage and Cell class | 4.91e-05 | 188 | 94 | 5 | 2331a2bae1383820d598e93aa86c75b101069bac | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_activate-7|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.03e-05 | 189 | 94 | 5 | ef33cc03728a78423ee92d2ef1ffed4918d4221f | |
| ToppCell | Control-B_naive-5|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.03e-05 | 189 | 94 | 5 | d39e112417a850f6e7b33315eab636fa90448301 | |
| ToppCell | Healthy-B_naive|World / disease group, cell group and cell class | 5.03e-05 | 189 | 94 | 5 | 1e533a43f739ff295740cf2b25479756dfb8e595 | |
| ToppCell | lymphoid-B_cell-Naive_B_cell|lymphoid / Lineage, cell class and subclass | 5.16e-05 | 190 | 94 | 5 | b8b05894e811e431d797ac4fa3ccff4963a154e7 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.16e-05 | 190 | 94 | 5 | 112706d64ee73b55dcf76f33ca064ab1fc6ce87f | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 5.16e-05 | 190 | 94 | 5 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | lymphoid-B_cell|lymphoid / Lineage, cell class and subclass | 5.16e-05 | 190 | 94 | 5 | c451de643ee08c2ff1093e807c65d724237473c5 | |
| ToppCell | severe-B_naive|World / disease stage, cell group and cell class | 5.16e-05 | 190 | 94 | 5 | 8dfe067d75573289299a5fba42b6c9b26e5fb430 | |
| ToppCell | Fetal_29-31_weeks-Immune-B_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.16e-05 | 190 | 94 | 5 | 424550418c1bd4eb070cf3c41cf09fa9d89aef37 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.16e-05 | 190 | 94 | 5 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.16e-05 | 190 | 94 | 5 | a7498fe55b7810c482291db782dc5282675d246a | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.16e-05 | 190 | 94 | 5 | 71e112dfb8c3190fe0286b45a046ea789eb6a8db | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.16e-05 | 190 | 94 | 5 | ee7b60cdf93c695ea2d59a170ca8cf4dc93e7eb2 | |
| ToppCell | severe-B_naive|severe / disease stage, cell group and cell class | 5.16e-05 | 190 | 94 | 5 | 2430a1fd18385305bf1b604747ff64026a8d5edf | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 5.29e-05 | 191 | 94 | 5 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.29e-05 | 191 | 94 | 5 | de2cd94ee88a7754f86d39469e38374d668210c7 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.29e-05 | 191 | 94 | 5 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | facs-Pancreas|facs / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 191 | 94 | 5 | d48e5f67d384226add7d7fb2a124954136e09a82 | |
| ToppCell | (3)_MNP-(3)_DC_1|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.29e-05 | 191 | 94 | 5 | cf0ea54670ed478c3302ccfbee9f6b6706e49fcd | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 5.42e-05 | 192 | 94 | 5 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 5.42e-05 | 192 | 94 | 5 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.56e-05 | 193 | 94 | 5 | 09a9ab029f01234459a88e3e994fe90ef4cbb8c6 | |
| Disease | Liver Cirrhosis, Experimental | SYNRG MYO1C AHNAK FXYD6 NLRC5 PRKCB LTB ALDH1B1 CPS1 VASP EPB41L2 | 1.54e-05 | 774 | 86 | 11 | C0023893 |
| Disease | dilated cardiomyopathy (is_implicated_in) | 2.71e-04 | 43 | 86 | 3 | DOID:12930 (is_implicated_in) | |
| Disease | glutaroyl carnitine measurement | 6.41e-04 | 13 | 86 | 2 | EFO_0021005 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 7.42e-04 | 139 | 86 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | urolithiasis | 8.37e-04 | 63 | 86 | 3 | MONDO_0024647 | |
| Disease | glutarylcarnitine (C5-DC) measurement | 1.11e-03 | 17 | 86 | 2 | EFO_0800030 | |
| Disease | thalamus volume | 1.99e-03 | 85 | 86 | 3 | EFO_0006935 | |
| Disease | proline measurement | 2.61e-03 | 26 | 86 | 2 | EFO_0009773 | |
| Disease | pain | 2.62e-03 | 196 | 86 | 4 | EFO_0003843 | |
| Disease | Squamous cell carcinoma of esophagus | 2.73e-03 | 95 | 86 | 3 | C0279626 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DDDPFNPQESKRFVQ | 431 | Q9H313 | |
| EDGQQKKARAPQAFP | 1096 | Q5SNV9 | |
| PLPEEEEQENNKSFN | 1931 | Q9NR48 | |
| PFELDTQQGPQVDKE | 351 | P30837 | |
| KVDINAPDVDVQGPD | 3131 | Q09666 | |
| QPNQEGPFDVKETEI | 2356 | P11532 | |
| LPEGFSQEFEEQQPK | 171 | Q7Z478 | |
| NQKPRAPGDEEAQVE | 66 | Q9H0Q3 | |
| ENVKPDFVQPRDVQE | 331 | Q5T5Y3 | |
| APEKEAPEFSGLQNQ | 131 | A6NI56 | |
| RRNQEIQQGEDAFPP | 16 | Q9UHB7 | |
| DPQEPQNNAHRDKEG | 121 | Q16790 | |
| FLKEFENPEVPREDQ | 416 | O60216 | |
| RKPENQQFPDTENEE | 416 | H3BUK9 | |
| GQEPEADSQELVQPK | 56 | O75459 | |
| FIDDDKPQQGLPEVA | 36 | Q8WWR9 | |
| PVNGSQEEAKPQVRD | 191 | Q9NZ53 | |
| ENPDEPKEGVNRSFL | 966 | Q9H2M9 | |
| RISEKPGAPEDNQEE | 256 | Q9NXN4 | |
| QPRESGNPEEEKVAA | 5296 | Q9NU22 | |
| LQNQKEAEEPGPDSE | 676 | Q8WXG6 | |
| QPDPVDQVLFDNEFD | 201 | Q5TCQ9 | |
| RGQSFNIAPQKEEPE | 6 | A4FU01 | |
| QRFQEGVDAKENPEE | 426 | Q9HDC5 | |
| KSENDPNLIPENGDE | 471 | Q9H165 | |
| EPLPEEQRQAKGDAE | 116 | O43491 | |
| RVKLEDENDNPPIFN | 456 | Q9HC56 | |
| GEEPRFQELPFRKNE | 446 | Q6P3R8 | |
| QPNEVPEDNLEGVEK | 541 | A0A1B0GTH6 | |
| EKENQEPLRSPEVGD | 671 | P48681 | |
| NRPPNFEAEKEFNET | 646 | O75164 | |
| NEFDELEIQGKLPDP | 2081 | Q5S007 | |
| KRQEEEPPTDNQGIA | 36 | Q5JRK9 | |
| HEQDTVAQFGPQKEP | 861 | Q96RT8 | |
| PPEGSEANEELRQKF | 291 | P05771 | |
| QRDPFAVQKDVENDG | 1066 | Q06190 | |
| QEPEEQKGPQERAAF | 946 | Q86WI3 | |
| NPEQDLFVEQKERNP | 2081 | Q9UPN3 | |
| PNKRNVPQGETEREY | 781 | Q7Z6E9 | |
| VQRGDDADQIEPPKV | 626 | Q8IZE3 | |
| QEEEKGPVSPRNLQE | 321 | Q9H094 | |
| PVQEAQEAPRKEEGA | 316 | Q5T0Z8 | |
| EGQPVDFVDPNKQNL | 186 | P31327 | |
| VNQKQEPGPAQEEAE | 446 | Q0VDD7 | |
| YLIKPPEENERENGQ | 766 | O14647 | |
| GEAKARPQEQESVQP | 801 | Q96PV7 | |
| INFDLPVDKDGNPDN | 406 | Q9UMR2 | |
| ERPENNKGGIFVIEQ | 2746 | Q8TDW7 | |
| EKPEEQDAQADNPSF | 546 | O60266 | |
| LNQNAKPEGPEQAEL | 386 | P41182 | |
| RNPDDPQAQEKFQDL | 56 | Q9UBS4 | |
| NNEDFAVLKPVDPDG | 586 | Q08554 | |
| NFDLPVDKDGNPDNE | 406 | Q9NUU7 | |
| LFSQQENGPPEEAEK | 546 | Q9NZ56 | |
| PNGFDLTEENPKRED | 396 | O43395 | |
| YQPQAKPEEEQENDP | 981 | P42702 | |
| KRQEEEPPTDNQGIA | 36 | Q7Z2X7 | |
| QKPQDPGDKEAQVEN | 66 | P58550 | |
| FVLENQPLKGNEEEP | 581 | P0C091 | |
| VLQFPQPGSKDAEER | 106 | Q5VWG9 | |
| PGPEDQEVEQQVQKE | 1191 | A8K8P3 | |
| KGLQNIDPENDPDVT | 1396 | Q9HCJ0 | |
| PANQVVKPEEDDFQD | 446 | Q9UMZ2 | |
| IPPGKEDQQAFTQGE | 1381 | O14513 | |
| RQEDPYGPQTKEVNE | 71 | O15226 | |
| NQNDDEEEEGKAPVP | 281 | P0C2Y1 | |
| RKPENQQFPDTENEE | 416 | A0A0A6YYL3 | |
| VDEVFKNAQPPIRDA | 916 | Q9UPR0 | |
| QDPSQEKPQAGELEA | 756 | O43147 | |
| VEGDPQTQLQDDKDP | 316 | Q6IA17 | |
| EQPDLNFRNPDVQEE | 281 | Q07837 | |
| SRKPPVFDENEDVNF | 6 | Q8WU08 | |
| DFLPRDQGVLPKDQN | 561 | Q0P6D6 | |
| AKETEQINGNPVPDE | 121 | Q8N999 | |
| LLPEEQQDPKQENGA | 471 | Q9H9A5 | |
| KNAPTPQEFREGEDA | 121 | P13591 | |
| NKAVNGAENDPFVRP | 371 | Q9UKI8 | |
| NVQTEFPGEDENPEK | 361 | Q9BYV6 | |
| PAPAVGEAEDKENQQ | 301 | P16989 | |
| QRKEVEQDPGPFNVP | 21 | A0A0B4J245 | |
| INDPTVKPINDDFRG | 566 | Q6ZVD7 | |
| APAQDQEELEAKAQP | 356 | Q6ZMY3 | |
| KDGQPQVVPVAADQR | 1511 | P22105 | |
| GAVAKVREAFQPQEP | 826 | P18206 | |
| QPEENTPLNGADKVF | 21 | Q5BVD1 | |
| IFDVLKEQAQPPENG | 841 | O95359 | |
| AEQKEHRLPPGQEEN | 496 | P18887 | |
| GAQETPAPQALEDKQ | 871 | Q5QJ38 | |
| EDVPFTEKDFENGPQ | 81 | Q6P5S7 | |
| EEVEQQKRQQPGPSE | 136 | P50552 | |
| QREPDENSGFNPDEI | 266 | Q5R3F8 | |
| QQGLGFQKLPEEEPE | 66 | Q06643 | |
| DQPEFDVPLKQDQEQ | 226 | P23276 | |
| IKPNDAKQPGRFDEV | 626 | O00159 | |
| NPEEVQKEGPTALQD | 96 | Q9BWU0 | |
| ERGFLPQPQQKDFDD | 136 | B2RTY4 | |
| PNDEGDPKALQQAAE | 61 | Q99608 |